Back to Authors

Agarwal, Suresh K

Mayo Clinic

AbbVie (United States)

Citations 1

Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8032-8032

10.1200/jco.2016.34.15_suppl.8032